Cybin is a company which focuses on the production and marketing of medical cannabis. It was listed in the Alt-X of the JSE 25th June 2024 as a special purpose acquisition company (SPAC) and plans to acquire Cilo Cybin Pharmaceutical. Cilo Cybin is to make 10% of its 71m ordinary shares available to the market - which probably means it will be very thinly traded at least to begin with. The company's CEO is Gabriel Theron.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。